Skip to main content
Premium Trial:

Request an Annual Quote

Gene Patent Case Presses On

The American Civil Liberties Union and the Public Patent Foundation are seeking a ruling from the US Supreme Court on the validity of gene patents, according to an ACLU statement. The plaintiffs are asking for redress from the high court in their case against Myriad Genetics' patents on the BRCA1 and BRCA2 genes, after a federal appeals court ruled in August that those patents were valid. According to our sister publication Pharmacogenomics Reporter, the Supreme Court could either choose to hear the case, or it could ask the Court of Appeals to reconsider its decision. A Myriad spokeswoman tells PGx Reporter the company is still considering its options, and that it has until December 15 to decide on its next steps.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.